7月30日，再生元制药公司盘中上涨3.19%，报704.7美元/股，成交额2.4亿美元。
消息面上，公司于盘前公布第二季度财报，业绩大幅超出市场预期。数据显示，Q2调整后每股收益为14.29美元，远超分析师一致预期的10.26美元，超出幅度达39.28%，较去年同期的12.89美元增长10.86%；营收达42.91亿美元，超出市场预期的38.16亿美元。值得注意的是，公司此前曾在SEC文件中预警Q2每股收益将减少约1美元，实际表现却大幅好于预期，推动股价快速上行。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.